Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3799 Target Snapshot

Neuromedin-K receptor · SINGLE PROTEIN · Cavia porcellus

59Compounds
35Assays
0Approved Drugs
67.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P30098. Use UniProt P30098 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P30098 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Neuromedin-K receptor as ChEMBL target CHEMBL3799, mapped to UniProt P30098. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Neuromedin-K receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL3799
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P30098
Neuromedin-K receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Neuromedin-K receptor is the right protein anchor across sources, using UniProt P30098 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNeuromedin-K receptor
UniProt AccessionP30098
Component TypeProtein
Sequence Length440 aa

Neuromedin-K receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Neuromedin-K receptor, mapped to UniProt P30098. Sequence length is 440 aa.

Mapped IDP30098
Review nameNeuromedin-K receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

1
Phase III
5
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5041.0
KI13.0
EC504.0
KD9.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL346178 10.1 Kd 0.08 Clinical
CHEMBL583102 9.22 EC50 0.6 Preclinical
CHEMBL346178 9.22 Ki 0.6 Clinical
CHEMBL2115415 9.14 IC50 0.72 Preclinical
CHEMBL81919 9.05 EC50 0.9 Preclinical
CHEMBL565894 8.8 Ki 1.6 Preclinical
CHEMBL437797 8.7 IC50 2.0 Preclinical
CHEMBL295615 8.57 IC50 2.7 Preclinical
CHEMBL567849 8.57 Ki 2.7 Preclinical
CHEMBL45340 8.43 IC50 3.7 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
3
5.5
5
6.0
3
6.5
0
7.0
17
7.5
10
8.0
6
8.5
5
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

35
Total Assays
35
Tested Compounds
2
Assay Types
Binding — 27 assays, 35 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 10 19 6.3
cell membrane format 8 11 7.6
cell-based format 6 5 8.8
single protein format 2 0
assay format 1 0
Functional — 8 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 4 3 8.4
cell-based format 3 6 8.1
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine